ESCRS - Supplement: New Medical Therapies and Modern MIGs Address Unmet Needs in Galucoma and Cataract Patient Care ;
Supplements

Supplement: New Medical Therapies and Modern MIGs Address Unmet Needs in Galucoma and Cataract Patient Care

Supplement: New Medical Therapies and Modern MIGs Address Unmet Needs in Galucoma and Cataract Patient Care

According to the 2020 ESCRS Clinical Trends Survey, an average of 21% of patients prescribed one or two topical glaucoma medications and 27% of those prescribed more than two topical glaucoma medications to control their condition are not compliant (Figure 1). It is a significant number of patients.

Tags: glaucoma
Latest Articles
ESCRS Research Projects Make a Difference

EPICAT study continues tradition of practice-changing clinical studies.

Read more...

Tablao Debates: Cataract-Refractive Edition

Lively debate format pairs EDOF lenses with trifocals in a dance for first prize in surgery choice.

Read more...

Going Beyond Cataract Camps

ESCRS expanding treatment opportunities in underserved areas.

Read more...

Bridging the Gap Between Local and Global

New training programmes seek to reach hard-to-reach areas to meet growing patient needs.

Read more...

2024 Congress Draws Global Audience, Strengthens Ties

Read more...

Refractive EDOF with the Benefits of Monofocal

PureSee IOL studies indicate high patient satisfaction.

Read more...

Making the Right IOL Decisions

Use of presbyopia-correcting lenses in post-corneal refractive surgery patients requires attention to multiple considerations.

Read more...

Training to Target Global Cataract Blindness

Non-profit organisations look to innovative, scalable virtual reality training systems.

Read more...

ESCRS Refractive Surgery Guidelines a Work in Progress

Challenges involve keeping up to date on current treatments.

Read more...

Stabilising with PACE-CXL

Performed with advanced technologies, PACE-CXL procedure stops ectatic progression and improves vision.

Read more...